Health
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections – Genetic Engineering & Biotechnology News
The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
If you think breathing in gene editing enzymes to treat infectious diseases, such as the flu or COVID-19, is a technology that is far-fetched or a long way off, think again. A team of investigators from the Georgia Institute of Technology and Emory University has developed a CRISPR-based treatment to stop the replication of both the flu virus and the virus that causes COVID-19 in mice. Moreover, the new treatment is delivered to the lungs via a nebulizer, which could make it simple for patients…
-
Business15 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General15 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains
-
Noosa News18 hours agoRates on hold; pressure builds for cuts in May